10.25375/uct.7970177.v1
Michele Tameris
Michele
Tameris
Helen Mearns
Helen
Mearns
Adam Penn-Nicholson
Adam
Penn-Nicholson
Yolande Gregg
Yolande
Gregg
Nicole Bilek
Nicole
Bilek
Simbarashe Mabwe
Simbarashe
Mabwe
Hennie Geldenhuys
Hennie
Geldenhuys
Justine Shenje
Justine
Shenje
Angelique Luabeya
Angelique
Luabeya
Ingrid Murillo
Ingrid
Murillo
Juana Doce
Juana
Doce
Nacho Aguilo
Nacho
Aguilo
Dessislava Marinova
Dessislava
Marinova
Esteban Rodriguez
Esteban
Rodriguez
Eugenia Pentes
Eugenia
Pentes
Jesús Gonzalo-Asensio
Jesús
Gonzalo-Asensio
Bernard Fritzell
Bernard
Fritzell
Jelle Thole
Jelle
Thole
Carlos Martin
Carlos
Martin
Thomas Scriba
Thomas
Scriba
Mark Hatherill
Mark
Hatherill
MTBVAC Clinical Trial Team
MTBVAC Clinical Trial
Team
Statistical Analysis Plan
University of Cape Town
2019
MTBVAC
infants
tuberculosis
clinical trial
Immunology
2019-07-29 12:31:44
Presentation
https://zivahub.uct.ac.za/articles/presentation/Statistical_Analysis_Plan/7970177
Statistical analysis plan for the MTBVAC 201 clinical trial. A phase Ib, randomised, double-blind, dose-escalation clinical trial of the safety, reactogenicity and immunogenicity of MTBVAC compared to BCG Vaccine SSI, in newborns living in a tuberculosis endemic region with a safety arm in adults.